Company: VRCA
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0001193125-25-135949
Chunk: 0

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-06-05
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 5, 2025, Verrica Pharmaceuticals Inc. (the “ Company”) held its 2025 annual meeting of stockholders (the “ Annual Meeting”). The stockholders considered four proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 22, 2025 (the “ Proxy Statement”). Of the 92,490,993 shares outstanding as of the record date, 83,426,756 shares, or 90%, were present or represented by proxy at the Annual Meeting. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.

Proposal No. 1: Election of three nominees to serve as directors until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows:

  Name                Votes For                      Votes Withheld                 
 ────────────────────────────────────────────────────────────────────────────────────
  Sean Stalfort                      60,322,237                          3,509,578  
  Diem Nguyen                        58,848,526                          4,983,289  
  Gavin Corcoran                     62,983,178                            848,637  

Broker Non-Votes: 19,594,941.

All nominees were elected.

Proposal No. 2: Approval, on an advisory basis, of the compensation paid to the Company’s named executive officers, as disclosed in the Proxy Statement. The votes were cast as follows:

                                                                 Votes For                      Votes Against                     Abstained              
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Advisory approval of named executive officer compensation                     62,418,833                         1,324,393                     88,589  

Broker Non-Votes: 19,594,941.

Proposal No. 3: Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025. The votes were cast as follows:

                                               Votes For                      Votes Against                     Abstained              
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Ratification of appointment of KPMG LLP                     81,857,824                         1,531,751                     37,181